To evaluate the physiological impact of high CPAP (≥9 cmH 2 O) vs. NIPPV at equivalent mean airway pressures. Preterm infants without any congenital or chromosomal/genetic abnormalities who were ...
Continuous positive airway pressure (CPAP) is a primary non-invasive respiratory support modality for preterm infants. While there are benefits to CPAP, evidence suggests it may contribute to ...
Adding two weeks of continuous positive airway pressure for preterm infants in the hospital substantially improves lung growth and function, according to new research from Oregon Health & Science ...
Extending the use of a continuous positive airway pressure (CPAP) treatment in premature infants by two weeks significantly increases lung volume and lung diffusion capacity, according to a new study.
Extending the use of a continuous positive airway pressure (CPAP) treatment in premature infants by two weeks significantly increases lung volume and lung diffusion capacity, according to a new study.
A clinical trial conducted in a neonatal intensive care unit has identified a new treatment protocol to improve lung growth and function among preterm infants. Adding two weeks of continuous positive ...
Extending the use of a continuous positive airway pressure (CPAP) treatment in premature infants by two weeks significantly increases lung volume and lung diffusion capacity, according to a new study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results